Eskild Landt

Dr. Eskild Landt

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
NDNikolaj Dietrich
Nikolaj Dietrich
MLMads Lerdrup
Mads Lerdrup
ELEskild Landt
Eskild Landt
SAShuchi Agrawal-Singh
Shuchi Agrawal-Singh
MBMads Bak
Mads Bak
KHKlaus Hansen
Klaus Hansen
Polycomb Repressive Complex (PRC) 1 and PRC2 regulate genes involved in differentiation and development. However, the mechanism for how PRC1 and PRC2 are recruited to genes in mammalian cells is unclear. Here we present evidence for an interaction between the transcription factor REST, PRC1, and PRC2 and show that RNF2 and REST co-regulate a number of neuronal genes in human teratocarcinoma cells (NT2-D1). Using NT2-D1 cells as a model of neuronal differentiation, we furthermore showed that retinoic-acid stimulation led to displacement of PRC1 at REST binding sites, reduced H3K27Me3, and increased gene expression. Genome-wide analysis of Polycomb binding in Rest−/− and Eed−/− mouse embryonic stem (mES) cells showed that Rest was required for PRC1 recruitment to a subset of Polycomb regulated neuronal genes. Furthermore, we found that PRC1 can be recruited to Rest binding sites independently of CpG islands and the H3K27Me3 mark. Surprisingly, PRC2 was frequently increased around Rest binding sites located in CpG-rich regions in the Rest−/− mES cells, indicating a more complex interplay where Rest also can limit PRC2 recruitment. Therefore, we propose that Rest has context-dependent functions for PRC1- and PRC2- recruitment, which allows this transcription factor to act both as a recruiter of Polycomb as well as a limiting factor for PRC2 recruitment at CpG islands. Multicellular organisms are composed of a large number of specialized cell types that all originate from the Embryonic Stem cell (ES cell). It is crucial for the maintenance of naïve ES cells that developmental genes are kept in an off-state until appropriate differentiation stimuli are received. Polycomb Repressive Complexes, PRC1 and PRC2, are bound at and repress the activity of a large number of key developmental genes in ES cells and at different stages of differentiation. While in Drosophila the PRC complexes are recruited to DNA elements called Polycomb Response Elements (PREs), through the interaction with transcription factors; examples of such factors remain poorly characterized in mammals. We here demonstrate that the transcription factor Rest interacts with and is required for recruitment of PRC1 and PRC2 to a subset of Rest target genes in mouse embryonic stem (mES) cells. In line with REST being a repressor of neuronal genes, we found that PRC1 and PRC2 co-localized with REST at genes involved in neuronal development and got displaced during neuronal differentiation. Based on our data we propose that the PRC1 and PRC2 complexes function as co-repressors for Rest to control the timed expression of developmental genes in the process of cellular differentiation.

1 October 2021 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
NKNanna Korsbæk
Nanna Korsbæk
ELEskild Landt
Eskild Landt
Morten DahlMorten Dahl
Morten Dahl
Rationale: Individuals exposed to second-hand smoking may be more susceptible to asthma and chronic obstructive pulmonary disease (COPD). We investigated the risk of respiratory symptoms, asthma, and COPD in adults exposed to second-hand smoking at different stages of life in the general population. Methods: We identified individuals who had been exposed to second-hand smoking in childhood only, adulthood only, or lifelong in a cohort of 20,421 adults from the Danish General Suburban Population Study and recorded respiratory symptoms, lung function, asthma, and COPD as outcomes. Results: Among 20,421 adults from the general population, 2,551 (12%) had been lifelong exposed to second-hand smoking, 459 (2%) had been exposed in adulthood only, and 13,998 (69%) had been exposed in childhood only; the mean ages of the three groups were 54 years, 55 years, and 57 years, respectably, compared with 56 years in non-exposed individuals (P< 0.001). Equivalent values for the prevalence of current smoking were 25%, 20%, and 18% versus 12% (P< 0.001). After adjustment for age, smoking, and sex, the odds ratios for wheezing, severe dyspnoea, cough on exertion, and asthma increased as a function of second-hand smoke exposure (Ps≤ 0.004); individuals who had been exposed to second-hand smoking lifelong, in adulthood only, or in childhood only versus non-exposed had increased odds ratios for wheezing of 1.62 (95% CI=1.41– 1.87), 1.50 (1.15– 1.94), and 1.16 (1.04– 1.30). Corresponding values were 2.08 (1.52– 2.85), 2.05 (1.22-3-44), and 1.23 (0.95– 1.59) for severe dyspnoea, 1.56 (1.33– 1.83), 1.53 (1.15– 2.02), and 1.19 (1.05– 1.35) for cough on exertion, 1.36 (1.14– 1.63), 1.49 (1.09– 2.05), and 1.13 (0.99– 1.30) for asthma, and 1.24 (1.03– 1.48), 1.25 (0.90– 1.74), and 1.09 (0.96– 1.24) for COPD. The population attributable fractions of asthma and COPD due to lifelong second-hand smoke exposure were 4.3% and 2.9%. Conclusion: Individuals exposed to lifelong second-hand smoking have increased risks of respiratory symptoms, asthma, and COPD, and may account for 4.3% and 2.9% of people with asthma and COPD in the general population.

6 July 2021 in Thorax
Verified
Journal Article
Closed access
PDF file
ELEskild Landt
Eskild Landt
YÇYunus Çolak
Yunus Çolak
BNBørge G Nordestgaard
Børge G Nordestgaard
PLPeter Lange
Peter Lange
Morten DahlMorten Dahl
Morten Dahl
Background: Obese individuals may be at higher risk of chronic cough. We investigated the risk and impact of chronic cough in obese individuals from the general population.Methods: We recorded chronic cough, body mass index (BMI) and other related clinical conditions in 44 554 adults from the Copenhagen General Population Study. Individuals with asthma and/or chronic obstructive pulmonary disease were excluded (n=10 977). BMI was divided into: underweight (BMI <18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2), obese (30.0–34.9 kg/m2) and severely obese (≥35.0 kg/m2).Results: Among 33 577 adults from the general population, 27 829 (83%) were non-obese and 5748 (17%) were obese. Compared with individuals with normal weight, multivariable adjusted ORs for chronic cough risk were 1.4 (95% CI 1.2 to 1.6) in overweight, 1.9 (95% CI 1.7 to 2.2) in obese and 2.6 (95% CI 2.1 to 3.2) in severely obese individuals. Mediation analyses showed that chronic cough due to obesity was up to 23% mediated by gastro-oesophageal reflux disease (GERD). Other mediators included low vegetable intake with 10% and occupational exposure with 8%. Among obese individuals, those with versus without chronic cough had worse accompanying respiratory symptoms, more often comorbidities including GERD and diabetes, greater healthcare utilisations, lower lung function and higher blood inflammation (all p<0.05).Conclusion: There is dose–response relationship between BMI and chronic cough, and chronic cough risk is twofold to threefold higher in obese individuals from the general population. This increased risk was partly mediated by GERD, low vegetable intake and occupational exposure, supporting that there may be benefit to gain by ameliorating some of these factors in obese individuals with chronic cough.

17 August 2023 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
SWSine V. Winther
Sine V. Winther
ELEskild Landt
Eskild Landt
BNBørge G. Nordestgaard
Børge G. Nordestgaard
NSNiels Seersholm
Niels Seersholm
Morten DahlMorten Dahl
Morten Dahl
Background: Individuals with α1-antitrypsin deficiency have increased elastase activity resulting in continuous degradation of elastin and early onset of COPD. Increased elastase activity may also affect elastic properties of the heart, which may impact risk of heart failure. We tested the hypothesis that α1-antitrypsin deficiency is associated with increased risk of heart failure in two large populations.Methods: In a nationwide nested study of 2209 patients with α1-antitrypsin deficiency and 21 869 controls without α1-antitrypsin deficiency matched on age, sex and municipality, we recorded admissions and deaths due to heart failure during a median follow-up of 62 years. We also studied a population-based cohort of another 102 481 individuals from the Copenhagen General Population Study including 187 patients from the Danish α1-Antitrypsin Deficiency Registry, all with genetically confirmed α1-antitrypsin deficiency.Results: Individuals withversuswithout α1-antitrypsin deficiency had increased risk of heart failure hospitalisation in the nationwide cohort (adjusted hazard ratio 2.64, 95% CI 2.25–3.10) and in the population-based cohort (1.77, 95% CI 1.14–2.74). Nationwide, these hazard ratios were highest in those without myocardial infarction (3.24, 95% CI 2.70–3.90), without aortic valve stenosis (2.80, 95% CI 2.38–3.29), without hypertension (3.44, 95% CI 2.81–4.22), without atrial fibrillation (3.33, 95% CI 2.75–4.04) and without any of these four diseases (6.00, 95% CI 4.60–7.82). Hazard ratios for heart failure-specific mortality in individuals withversuswithout α1-antitrypsin deficiency were 2.28 (95% CI 1.57–3.32) in the nationwide cohort and 3.35 (95% CI 1.04–10.74) in the population-based cohort.Conclusion: Individuals with α1-antitrypsin deficiency have increased risk of heart failure hospitalisation and heart failure-specific mortality in the Danish population.

15 December 2023 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
ELEskild Landt
Eskild Landt
YÇYunus Çolak
Yunus Çolak
BNBørge G. Nordestgaard
Børge G. Nordestgaard
PLPeter Lange
Peter Lange
Morten DahlMorten Dahl
Morten Dahl
Background: Chronic cough affects up to 10% of the general population and was previously perceived as a comorbidity of underlying conditions, but is nowadays classified as a disease in its own entity that could confer increased risk of morbidity and mortality. We tested the hypothesis that chronic cough is associated with increased risk of COPD exacerbation, pneumonia and all-cause mortality in the general population.Methods: We identified 2801 individuals with chronic cough, defined as cough lasting >8 weeks, among 44 756 randomly selected individuals from the Copenhagen General Population Study, and recorded COPD exacerbations, pneumonia and all-cause mortality during follow-up.Results: During up to 5.9 years of follow-up (median 3.4 years), 173 individuals experienced COPD exacerbation, 767 experienced pneumonia and 894 individuals died. Individuals with chronic coughversusthose without had cumulative incidences at age 80 years of 12%versus3% for COPD exacerbation, 30%versus15% for pneumonia, and 25%versus13% for death from all causes. After adjustment for age, sex and smoking, individuals with chronic coughversusthose without had adjusted hazard ratios of 4.6 (95% CI 2.9–7.2) for COPD exacerbation, 2.2 (1.7–2.7) for pneumonia and 1.7 (1.4–2.0) for all-cause mortality. Among current smokers aged >60 years with airflow limitation, those withversuswithout chronic cough had an absolute 5-year risk of 10%versus4% for COPD exacerbation, 16%versus8% for pneumonia and 19%versus12% for all-cause mortality.Conclusion: Chronic cough is associated with higher risks of COPD exacerbation, pneumonia and death, independent of airflow limitation and smoking.

14 November 2022 in Journal of Asthma
Verified
Journal Article
Closed access
KÖKudret C. Özdemir
Kudret C. Özdemir
RJRamune Jacobsen
Ramune Jacobsen
MDMorten Dahl
Morten Dahl
ELEskild Landt
Eskild Landt
Asthma medication adherence is of crucial importance for successful disease management. The aim of this study was to identify and rank factors associated with medication adherence among adults with...